Testing for ROS1 in non-small cell lung cancer: a review with recommendations
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Testing for ROS1 in non-small cell lung cancer: a review with recommendations
Authors
Keywords
Fluorescence in situ hybridisation, Immunohistochemistry, Non-small cell lung cancer, Predictive marker, ROS1, RT-PCR
Journal
VIRCHOWS ARCHIV
Volume 469, Issue 5, Pages 489-503
Publisher
Springer Nature
Online
2016-08-17
DOI
10.1007/s00428-016-2000-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance
- (2016) Quan Zhang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Bronchoscopic Re-biopsy for Mutational Analysis of Non-small Cell Lung Cancer
- (2016) Keisuke Kirita et al. LUNG
- Clinical Implications of Genomic Discoveries in Lung Cancer
- (2016) Charles Swanton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches
- (2015) A. Drilon et al. CLINICAL CANCER RESEARCH
- ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer
- (2015) Theresa A. Boyle et al. Clinical Lung Cancer
- ALKandROS1rearrangements tested by fluorescencein situhybridization in cytological smears from advanced non-small cell lung cancer patients
- (2015) Cecilia Bozzetti et al. DIAGNOSTIC CYTOPATHOLOGY
- Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort
- (2015) Julien Mazières et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Methods in the Detection of ALK and ROS1 Rearrangements in Lung Cancer
- (2015) Toni-Maree Rogers et al. Journal of Thoracic Oncology
- MINI ORAL SESSIONS
- (2015) Journal of Thoracic Oncology
- Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing
- (2015) Philipp Jurmeister et al. LUNG CANCER
- The Frequency and Clinical Implication of ROS1 and RET Rearrangements in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Patients
- (2015) Sha Fu et al. PLoS One
- Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group
- (2015) Manfred Dietel et al. THORAX
- Erratum to: ROS1 gene rearrangement and copy number gain in non-small cell lung cancer
- (2015) Yan Jin et al. VIRCHOWS ARCHIV
- Detection of lung adenocarcinoma with ROS1 rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic features
- (2015) Bing Cao et al. OncoTargets and Therapy
- Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer
- (2015) Anna Karlsson et al. Oncotarget
- Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients
- (2015) Rui Wang et al. Oncotarget
- ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability
- (2015) Matthias Scheffler et al. Oncotarget
- Detection of ROS1 Gene Rearrangement in Lung Adenocarcinoma: Comparison of IHC, FISH and Real-Time RT-PCR
- (2015) Ling Shan et al. PLoS One
- Multiplex genomic profiling of non–small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study
- (2015) Isamu Okamoto et al. Oncotarget
- Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
- (2014) K. M. Kerr et al. ANNALS OF ONCOLOGY
- Immunohistochemistry Practices of Cytopathology Laboratories: A Survey of Participants in the College of American Pathologists Nongynecologic Cytopathology Education Program
- (2014) Andrew H. Fischer et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
- (2014) E. Felip et al. Clinical & Translational Oncology
- ROS1expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases
- (2014) Arne Warth et al. HISTOPATHOLOGY
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- (2014) Mark G. Kris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer
- (2014) Maruja E. Lira et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Detection of Rearrangements and Transcriptional Up-Regulation of ALK in FFPE Lung Cancer Specimens Using a Novel, Sensitive, Quantitative Reverse Transcription Polymerase Chain Reaction Assay
- (2014) Kim Gruber et al. Journal of Thoracic Oncology
- Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing
- (2014) Evgeny A. Moskalev et al. LUNG CANCER
- Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma
- (2014) Min Hwan Kim et al. LUNG CANCER
- Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma
- (2014) Seung Eun Lee et al. MODERN PATHOLOGY
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Anchored multiplex PCR for targeted next-generation sequencing
- (2014) Zongli Zheng et al. NATURE MEDICINE
- First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
- (2014) Benjamin J. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
- (2014) Yoon Jin Cha et al. PLoS One
- The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization
- (2014) Lien Tembuyser et al. PLoS One
- Detecting ALK, ROS1 and RET Fusion Genes in Cell Block Samples
- (2014) Chao Zhao et al. Translational Oncology
- ROS1 gene rearrangement and copy number gain in non-small cell lung cancer
- (2014) Yan Jin et al. VIRCHOWS ARCHIV
- Prognostic and predictive biomarkers in lung cancer. A review
- (2014) Erik Thunnissen et al. VIRCHOWS ARCHIV
- Responses to crizotinib in a patient with c-ros oncogene 1, receptor tyrosine kinase-positive advanced lung adenocarcinoma: A case report
- (2014) NA ZHANG et al. Oncology Letters
- ROS1-Rearranged Lung Cancer
- (2013) Akihiko Yoshida et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- ROS1 Immunohistochemistry for Detection of ROS1-Rearranged Lung Adenocarcinomas
- (2013) Lynette M. Sholl et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma
- (2013) H. R. Kim et al. ANNALS OF ONCOLOGY
- ROS1 fusions in Chinese patients with non-small-cell lung cancer
- (2013) W. Cai et al. ANNALS OF ONCOLOGY
- Molecular Pathways: ROS1 Fusion Proteins in Cancer
- (2013) K. D. Davies et al. CLINICAL CANCER RESEARCH
- Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors
- (2013) Neal I. Lindeman et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Clinicopathologic Analysis of ROS1-Rearranged Non–Small-Cell Lung Cancer and Proposal of a Diagnostic Algorithm
- (2013) Heounjeong Go et al. Journal of Thoracic Oncology
- On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas
- (2013) Lénaïg Mescam-Mancini et al. LUNG CANCER
- Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers
- (2013) Akihiko Yoshida et al. MODERN PATHOLOGY
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Targets in Non-Small Cell Lung Cancer: ROS1 and RET Fusions
- (2013) J. F. Gainor et al. ONCOLOGIST
- CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma
- (2013) SHUN MATSUURA et al. ONCOLOGY REPORTS
- Mouse Model for ROS1-Rearranged Lung Cancer
- (2013) Yasuhito Arai et al. PLoS One
- Role of Fluorescence in situ Hybridization in Lung Cancer Cytology
- (2012) Spasenija Savic et al. ACTA CYTOLOGICA
- The Oncogenic Lung Cancer Fusion Kinase CD74-ROS Activates a Novel Invasiveness Pathway through E-Syt1 Phosphorylation
- (2012) H. J. Jun et al. CANCER RESEARCH
- Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
- (2012) Ramaswamy Govindan et al. CELL
- Identifying and Targeting ROS1 Gene Fusions in Non-Small Cell Lung Cancer
- (2012) K. D. Davies et al. CLINICAL CANCER RESEARCH
- Analysis of Receptor Tyrosine Kinase ROS1-Positive Tumors in Non-Small Cell Lung Cancer: Identification of a FIG-ROS1 Fusion
- (2012) V. M. Rimkunas et al. CLINICAL CANCER RESEARCH
- Identification of KIF5B-RET and GOPC-ROS1 Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase Fusions
- (2012) Y. Suehara et al. CLINICAL CANCER RESEARCH
- The transcriptional landscape and mutational profile of lung adenocarcinoma
- (2012) J.-S. Seo et al. GENOME RESEARCH
- ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
- (2012) Kristin Bergethon et al. JOURNAL OF CLINICAL ONCOLOGY
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- RET, ROS1 and ALK fusions in lung cancer
- (2012) Kengo Takeuchi et al. NATURE MEDICINE
- EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations
- (2012) Erik Thunnissen et al. VIRCHOWS ARCHIV
- A Screening Method for the ALK Fusion Gene in NSCLC
- (2012) Yoshiko Murakami et al. Frontiers in Oncology
- External quality control for immunocytochemistry on cytology samples: a review of UK NEQAS ICC (cytology module) results
- (2011) I. S. Kirbis et al. CYTOPATHOLOGY
- Case 21-2011
- (2011) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Formalin Fixation at Low Temperature Better Preserves Nucleic Acid Integrity
- (2011) Gianni Bussolati et al. PLoS One
- Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers
- (2011) Chenguang Li et al. PLoS One
- Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
- (2010) R. J. Leary et al. Science Translational Medicine
- The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer
- (2008) Jaime Acquaviva et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now